RE:Not sure if this has been shared ! Thanks Oden...you must be a research fellow of Eoganacht's ; ).
Speaking of a non-exclusive two-pronged attack, our Ru-based technology also has great vaccine potential to protect against common viral infections as was demonstrated in Dr. Coombs' lab. Preclinically, TLD-1433 was able to kill Zika, influenza & human coronaviruses within seconds & in low-nanomolar concentrations. This compound could represent a very rapid & safe alternative to standard methods of how inactivated viral vaccines are manufactured, which are time intensive, costly, & often lead to marginal vaccine efficacy. Lots of great news coming on many fronts imo.